Patients with autoimmune polyendocrine syndrome type 1 (APS-1), which arises due to mutations in the autoimmune regulator gene (AIRE), exhibit antibodies against type I IFNs (IFN-α and IFN-ω) (69). This evidence concerns the gene AIRE and autoimmune polyendocrine syndrome type 1.